Information
-
Trademark
-
79149152
-
Serial Number
79149152
-
Registration Number
4774665
-
International Classifications
- 5 - Pharmaceutical and veterinary preparations
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
- 42 - Scientific and technological services and research and design relating thereto
-
Filing Date
April 29, 2014
10 years ago
-
Registration Date
July 21, 2015
9 years ago
-
Transaction Date
July 21, 2024
6 months ago
-
Status Date
May 01, 2022
2 years ago
-
Published for Opposition Date
May 05, 2015
9 years ago
-
Location Date
May 01, 2022
2 years ago
-
Status Code
708
-
Employee Name
DINALLO, KEVIN M
-
Attorney Docket Number
ASEDACI-5-T
Attorney Name
Jeffrey A. Smith
Law Office Assigned Location Code
L70
-
Owners
Mark Drawing Code
4
Mark Identification
SYSTEMETRIC
Case File Statements
- GS0091: [ Scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometry analyzers for cellular analysis; scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometers for single cell and population based cellular analysis; Laboratory apparatus and instruments, namely, protein separation and isolation instruments, flow cytometers, and laboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growing, maintaining, evaluating and quality control of cell cultures, automated liquid dispensing, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes; chemistry apparatus and instruments for maintaining, evaluating and quality control of cell cultures, automated liquid dispensing of compound preparations and chemical reagents, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes ]
- GS0051: [ In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use ]
- GS0421: Scientific research and development; scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing services [ and protein isolation ] for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect, and scientific research and development relating thereto; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] scientific research services; scientific testing and analysis in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] pharmaceutical research and development; Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]
Case File Event Statements
-
7/19/2014 - 10 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
8/25/2014 - 10 years ago
7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Type: RFWR
-
7/29/2014 - 10 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
8/2/2014 - 10 years ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
8/13/2014 - 10 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
8/21/2014 - 10 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/22/2014 - 10 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
8/26/2014 - 10 years ago
10 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
2/27/2015 - 9 years ago
17 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/25/2014 - 10 years ago
8 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/26/2014 - 10 years ago
9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
8/26/2014 - 10 years ago
11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
9/11/2014 - 10 years ago
12 - REFUSAL PROCESSED BY IB
Type: RFNP
-
10/23/2014 - 10 years ago
13 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
10/23/2014 - 10 years ago
14 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
2/26/2015 - 9 years ago
15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/26/2015 - 9 years ago
16 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/27/2015 - 9 years ago
20 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
4/15/2015 - 9 years ago
22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
5/5/2015 - 9 years ago
26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/21/2015 - 9 years ago
27 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
10/21/2015 - 9 years ago
28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
12/2/2015 - 9 years ago
29 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
12/2/2015 - 9 years ago
30 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
3/9/2015 - 9 years ago
18 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
3/27/2015 - 9 years ago
19 - ASSIGNED TO LIE
Type: ALIE
-
4/15/2015 - 9 years ago
21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
4/15/2015 - 9 years ago
23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
5/2/2015 - 9 years ago
24 - NOTIFICATION PROCESSED BY IB
Type: GPNX
-
5/5/2015 - 9 years ago
25 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
7/21/2020 - 4 years ago
32 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Type: REM3
-
1/4/2016 - 9 years ago
31 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
7/21/2021 - 3 years ago
33 - TEAS SECTION 71 & 15 RECEIVED
Type: ES75
-
2/16/2022 - 2 years ago
34 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
4/7/2022 - 2 years ago
35 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
5/1/2022 - 2 years ago
36 - REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Type: C75P
-
5/1/2022 - 2 years ago
37 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Type: NA75
-
2/22/2023 - a year ago
40 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Type: INPS
-
3/27/2023 - a year ago
41 - LIMITATION OF GOODS RECEIVED FROM IB
Type: LIMG
-
3/28/2023 - a year ago
42 - PARTIAL INVALIDATION PROCESSED BY THE IB
Type: INNP
-
6/7/2023 - a year ago
43 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Type: LIMN
-
1/1/2023 - 2 years ago
38 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Type: INPR
-
2/22/2023 - a year ago
39 - INVALIDATION PROCESSED
Type: INPC
-
7/21/2024 - 6 months ago
45 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Type: REM4
-
4/4/2024 - 9 months ago
44 - INTERNATIONAL REGISTRATION RENEWED
Type: RNWL